Massive heart study hopes troponin test outperforms old risk tools
NCT ID NCT04903041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a high-sensitivity troponin blood test can better sort people into low, moderate, or high risk for heart disease compared to standard checks. Researchers will enroll up to 300,000 adults in India who are already getting routine health screenings. The goal is to improve early detection and guide lifestyle or treatment recommendations to reduce heart attacks and strokes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2019
- Expected to finish
-
Sep 2030
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All subjects undergoing health checks at Apollo Group of hospitals in Hyderabad, Chennai, Bangalore, Mumbai, Kolkata and New Delhi.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. All men and women above the age of 18 years 2. Lipid profiles ordered 3. HbA1c ordered 4. Creatinine ordered Exclusion Criteria: 1\. Non-consenting subjects
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
6 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Apollo Hospitals
Bangalore, India
-
Apollo Hospitals
Chennai, India
-
Apollo Hospitals
Hyderabad, India
-
Apollo Hospitals
Kolkata, India
-
Apollo Hospitals
Mumbai, India
-
Apollo Hospitals
New Delhi, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could monthly texts and automatic risk scores stop heart attacks before they start?
- Can a nurse and a neighbor help tame chronic disease?
- Two eggs a day put to the test for heart health
- A soft patch that watches your heart beat in real time
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Inhaled drug aims to ease dangerous lung blood pressure in scarred lungs